Mills & Reeve
- Regulatory and compliance (3)
- Clinical/Medical Negligence (2)
- Crime (2)
- Healthcare (2)
- Agriculture (1)
- Banking / Finance (1)
- Company/Commercial (1)
- Competition/EU (1)
- Funds (1)
- Information Technology (1)
- Intellectual Property (1)
- Licensing/Gaming/Betting (1)
- Litigation / Dispute Resolution (1)
- Media/Entertainment/Sport (1)
- Transport (Including aviation and shipping) (1)
Sort By: Newest first | Oldest first
Technology businesses should be aware that the European Commission has revised the rules on how EU competition law affects technology licensing agreements.
Animal welfare: recent EU conference — mid-term review of the strategy for the welfare of animals 2012–15 download
The conference on the achievements of the EU strategy for the welfare of animals 2012–15: mid-term review took place on 12 February 2014.
There were developments last month in the ongoing discussions around the need for greater regulation of cosmetic medical devices.
The great doping debate in sport download
New research suggests that athletes using steroids for only a short period could gain an unfair advantage over ‘clean’ competitors for up to 10 years.
Privatising Plasma? download
US private equity firm Bain Capital has recently acquired an 80 per cent stake in blood products company Plasma Resources UK for £230m.
Mills & Reeve has advised Sphere Fluidics on its recent £1.65m series A funding from a syndicate of investors.
Patients First and Foremost, the government’s initial response to the Francis Report, was published just before Easter.
This briefing is intended to cut through the pages of small print and to see where CCGs will stand in the new world order when it comes to planning and securing services for patients.